FineHeart’s latest patents in the US, China, Japan & India brings us close to 150 patents worldwide
FineHeart widens international IP protection for FlowMaker®
Bordeaux, France, February 20, 2024 - FineHeart S.A., a clinical stage medical device company developing innovative devices for cardiology today announced the successful filing of six new international patents for its FlowMaker®, a fully implantable device for the treatment of patients with advanced heart failure.